CoChat

Pro-Active Call Center Treatment Support (PACCTS) to Improve Glucose Control in Type 2 Diabetes

Open access
Young, Robert J., Taylor, Jean, Friede, Tim, Hollis, Sally, Mason, James M., Lee, Pauline, Burns, Edna, Long, Andrew F., Gambling, Tina, New, John P., Gibson, J. Martin · 2005 · Diabetes Care
Cited by 105

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVE— To determine whether Pro-Active Call Center Treatment Support (PACCTS), using trained nonmedical telephonists supported by specially designed software and a diabetes nurse, can effectively improve glycemic control in type 2 diabetes. RESEARCH DESIGN AND METHODS— A randomized controlled implementation trial of 1-year duration was conducted in Salford, U.K. The trial comprised 591 randomly selected individuals with type 2 diabetes. By random allocation, 197 individuals were assigned to the usual care (control) group and 394 to the PACCTS (intervention) group. Lifestyle advice and drug treatment in both groups followed local guidelines. PACCTS patients were telephoned according to a protocol with the frequency of calls proportional to the last HbA1c level. The primary outcome was absolute reduction in HbA1c, and the secondary outcome was the proportion of patients reducing HbA1c by at least 1%. RESULTS— A total of 332 patients (84%) in the PACCTS group and 176 patients (89%) in the control group completed the study. Final HbA1c values were available in 374 patients (95%) in the PACCTS group and 180 patients (92%) in the usual care group. Compared with usual care, HbA1c improved by 0.31% (95% CI 0.11–0.52, P = 0.003) overall in the PACCTS patients. For patients with baseline HbA1c >7%, the improvement increased to 0.49% (0.21–0.77, P < 0.001), whereas in patients with baseline HbA1c <7% there was no change. The difference in the proportions of patients achieving a ≥1% reduction in HbA1c significantly favored the PACCTS intervention: 10% (4–16, P < 0.001) overall and 15% (7–24, P < 0.001) for patients with baseline HbA1c >7%. CONCLUSIONS— In an urban Caucasian trial population with blood glucose HbA1c >7%, PACCTS facilitated significant improvement in glycemic control. Further research should extend the validity of findings to rural communities and other ethnic groups, as well as to smoking and lipid and blood pressure control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.28.2.278

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 12

  1. UK Prospective Diabetes Study Group (UKPDS 33): Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837–853, 1998 · DOI · Paper page
  2. UK Prospective Diabetes Study Group: Cost-effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317:720–763, 1998 · DOI · Paper page
  3. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 317:713–720, 1998 · DOI · Paper page
  4. Edwards R, Burns JA, McElduff P, Young RJ, New JP: Variations in process and outcomes of diabetes care by socio-economic status in Salford, UK. Diabetologia 46:750–759, 2003 · DOI
  5. Haynes RB, McDonald H, Garg AX, Montague P: Helping patients follow prescribed treatment: clinical applications. JAMA 288:2880–2883, 2002 · DOI · Paper page
  6. Klonoff DC: Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? (Editorial). Diabetes Care 26:1626–1628, 2003 · DOI · Paper page
  7. Long AF, Gambling T, Young RJ, Taylor J, Mason JM, the PACCTS Team: Acceptability and satisfaction with a telecarer approach to the management of type 2 diabetes. Diabetes Care 28:283–289, 2004 · DOI
  8. Biermann E, Dietrich W, Rihl J, Standl E: Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomised, controlled trial. Comput Methods Prog Biomed 69:137–146, 2002 · DOI
  9. Gomez EJ, Hernando ME, Garcia A, Del Pozo F, Cermeno J, Corcoy R, Brugues E, De Leiva A: Telemedicine as a tool for intensive management of diabetes: the DIABTel experience. Comput Methods Prog Biomed 69:163–177, 2002 · DOI · Paper page
  10. Howells L, Wilson AC, Skinner TC, Newton R, Morris A, Greene SA: A randomised control trial of the effect of negotiated telephone support on glycaemic control in young people with type 1 diabetes. Diabet Med 19:643–648, 2002 · DOI · Paper page
  11. Izquierdo RE, Knudson PE, Meyer S, Kearns J, Ploutz-Snyder R, Weinstock RS: A comparison of diabetes education administered through telemedicine versus in person. Diabetes Care 26:1002–1007, 2003 · DOI · Paper page
  12. Piette JD, Weinberger M, McPhee SJ: The effect of automated calls with telephone nurse follow-up on patient-centered outcomes of diabetes care: a randomized, controlled trial. Med Care 38:218–230, 2000 · DOI · Paper page

Cited by

See all 105

Metadata

Authors
Young, R. J., Taylor, J., Friede, T., Hollis, S., Mason, J. M., Lee, P., Burns, E., Long, A. F., Gambling, T., New, J. P., & Gibson, J. M.
Venue
Diabetes Care
Published
2005-02-01
Volume
28
Issue
2
Pages
278-282
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2074643240
Cited by
105
References
7
FWCI
3.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pro-Active Call Center Treatment Support (PACCTS) to Improve Glucose Control in Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/diacare.28.2.278
The paper
Young, R. J., Taylor, J., Friede, T., Hollis, S., Mason, J. M., Lee, P., Burns, E., Long, A. F., Gambling, T., New, J. P., & Gibson, J. M. (2005). Pro-Active Call Center Treatment Support (PACCTS) to Improve Glucose Control in Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.28.2.278

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.